← Leaderboards
Benjamin Huang
University Of California, San Francisco
$1,239,925
Attributed
$1,239,925
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $248K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,239,925 · 1
By mechanism
K08$1,239,925 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Scott W Biggins$609,930
- Iwei Yeh$4,800,085
- Eric Collisson$14,159,893
- Qing Li$7,606,806
- Jasmine Ching Ying Wong$730,345
Others in their field
Other Emerging Leaders on “Acute Lymphocytic Leukemia”
- Crystal Mackall · Children'S Hosp Of Philadelphia$12,361,966
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,557,384
- Adam De Smith · University Of Southern California$5,277,579
- Karen R Rabin · Baylor College Of Medicine$4,946,686
- Ernesto Guccione · Icahn School Of Medicine At Mount Sinai$4,876,508
Research focus
Acute Lymphocytic LeukemiaDrug ResistanceAcute Myelocytic LeukemiaAdult Acute Myeloblastic LeukemiaDrug CombinationsApoptosisAutomobile DrivingAdolescent And Young AdultBiological ModelsBromodomainAlternative TherapiesAcute Myeloid Leukemia CellCell LineChemotherapy-Oncologic ProcedureChildChildhood Acute Myeloid LeukemiaChildhood LeukemiaCohortCombined Modality TherapyCongenicCrispr InterferenceDependenceDiagnosisDrug Synergism
Grant awards (5)
Co-targeting BET Bromodomain Proteins and Aberrant Signaling in AML.$247,985
K08 · FY2025 · CA · contact PI
Co-targeting BET Bromodomain Proteins and Aberrant Signaling in AML.$247,985
K08 · FY2024 · CA · contact PI
Co-targeting BET Bromodomain Proteins and Aberrant Signaling in AML.$247,985
K08 · FY2023 · CA · contact PI
Co-targeting BET Bromodomain Proteins and Aberrant Signaling in AML.$247,985
K08 · FY2022 · CA · contact PI
Co-targeting BET Bromodomain Proteins and Aberrant Signaling in AML.$247,985
K08 · FY2021 · CA · contact PI